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Abstract
Hypertensive crises in children or adolescents are rare, but chronic kidney disease (CKD) is a major
risk factor for occurrence. Vesicoureteral reflux nephropathy is a common cause of pediatric renal
failure and is associated with hypertension. Aggressive blood pressure (BP) control has been shown
to delay progression of CKD and treatment is targeted for the 50th percentile for height when com-
pared with a target below the 90th percentile for the general pediatric hypertensive patient. We
present a case of an adolescent presenting with seizures and renal failure due to a hypertensive
crisis. Hypertension was thought to be secondary to CKD as she had scarred echogenic kidneys due
to known reflux nephropathy. However, aggressive BP treatment improved kidney function which is
inconsistent with CKD from reflux nephropathy. Secondly, aggressive BP control caused transient
neurological symptoms. Further imaging identified moyamoya disease. We present this case to
highlight the consideration of moyamoya as a diagnosis in the setting of renal failure and hyper-
tensive crisis.
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Introduction
Severe hypertension in pediatric patients is thought to be
secondary and often related to renovascular disease. For
this reason, pediatric nephrologists have become the blood
pressure (BP) specialists for children with hypertension. In
children, neurological causes of hypertension are often
related to increased intracranial pressure whereas cerebro-
vascular causes are rare. The neurological consequences
of hypertension are stroke, seizures and encephalopathy.
Therefore, it is often presumed that renovascular disease
leads to hypertension which leads to neurological disease.
We report a case of neurological disease, moyamoya, cau-
sing hypertension, leading to partially reversible kidney
failure. We present this case to highlight the consideration of
moyamoya as a cause of hypertensive renal failure.
Case presentation
Emergent management
A 16-year-old adolescent female awoke with severe head-
ache early in the morning. Paracetamol (acetaminophen)
was taken, but offered no relief. Over the next 4 h the
headache was unremitting and she developed nausea
with emesis. She had sudden incoherence of speech with
bowel and bladder incontinence. She was taken to a local
hospital and was noted to have a focal seizure with left
facial and hand twitching which stopped with intravenous
lorazepam. A computed tomography (CT) scan of the
head without contrast was normal. BP was 200/140
mmHg. A single dose of hydralazine 10 mg was adminis-
tered intravenously. After stabilization she was transferred
by air to a tertiary care center. Upon arrival she was ad-
mitted to the pediatric intensive care unit. BP remained
elevated at 228/123 mmHg. She was encephalopathic
with left hemiparesis. She began vomiting. She was intu-
bated for airway protection. She was immediately placed
on an intravenous infusion of nicardipine at 0.5 µg/kg/min
without a bolus dose. An intra-arterial BP catheter was
placed to allow titration of the nicardipine infusion. Chest
X-ray showed bilateral perihilar infiltrates consistent with
pulmonary edema. Continuous electroencephalogram
did not reveal seizures, but right hemispheric slowing.
The target BP for the first 8 h was to maintain above
171/105 mmHg (<25% reduction in maximum BP for both
systolic and diastolic) to prevent a precipitous drop and
avoid inducing irreversible neurological damage.
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Past medical history was significant for grade III vesi-
coureteral reflux (VUR) diagnosed at age 12 after CT scan
for appendicitis identified acute appendicitis and scarring
of the upper poles of both kidneys. She had bilateral uret-
eral implantation at the age of 13. She had been seen in an
outpatient pediatric nephrology clinic 9 months prior to this
presentation. Systolic BP at that time was 120 mmHg; Hgb
75.1 mmol/L (12.1 g/dL); serum creatinine was 79.6 µmol/L
(0.9 mg/dL) [eGFR 78 mL/min/1.73 m2]; urinalysis with 3+
protein, without hematuria.
Current laboratory studies showed a serum creatinine of
415.5 µmol/L (4.7 mg/dL). Urinalysis showed 3+ protein and
3+ blood without red blood cells or casts on microscopy.
Drug screen was negative except for benzodiazepines.
White blood cell count was 14.4K/mm3 with 94% neutro-
phils; Hgb 67.6 mmol/L (10.9 g/dL). Magnetic resonance
imaging (MRI)/magnetic resonance angiography (MRA)
without contrast showed abnormal T2/FLAIR signal in the
cortical and subcortical regions of the right parietal tem-
poral lobe and basal ganglia consistent with either subacute
infarction in the right MCA territory without diffusion restric-
tion or an atypical presentation of posterior reversible
encephalopathy syndrome (PRES) (Figure 1A and B). MRA re-
vealed diminished flow in the right M1 segment (Figure 2).
Renal ultrasound showed small echogenic kidneys bilater-
ally (right 6.9 cm; left 7.8 cm) with cortical scarring and loss
of corticomedullary differentiation. Ultrasound was felt to
be consistent with and supported VUR nephropathy as the
cause of the hypertensive renal failure.
Initial hospital course
Over the next 96 h intravenous nicardipine (dose range of
2–10 µg/kg/min) and furosemide (0.1 mg/kg/h) were
infused in an attempt to normalize BP to less than the
90th percentile for height (126/81 mmHg) (Figure 3). Her
mental and neurological status returned to baseline
without appreciable deficits and she was extubated. Over
a 2-week hospital course she was transitioned to oral anti-
hypertensive agents including amlodipine 5 mg twice
daily, atenolol 50 mg daily, clonidine 0.1 mg twice daily, li-
sinopril 2.5 mg twice daily and furosemide 40 mg twice
daily (Figure 3). Evaluation for autoimmune disease and
vasculitis included ANA, ANCA, anti-GBM antibodies—all
were negative. Complement levels: C3 and C4 were normal.
ESR was elevated at 83 mm/h. Repeat MRI/MRA without
contrast showed near complete resolution of previously
seen T2/FLAIR hyperintensities although there was no flow
in the right M1 and A1 segment. Even with this persistent
MRA abnormality, her rapid return to normal without
neurological deficit and near-complete resolution of FLAIR
signal abnormalities was thought to be most consistent
with PRES. Furthermore, kidney function remained compro-
mised (creatinine peaked at 645.3 µmol/L [7.3 mg/dL];
eGFR 10 mL/min/1.73 m2), and therefore we were reluctant
to proceed with a conventional angiogram as it was likely
to result in the need for dialysis due to contrast nephropa-
thy. She was discharged home on four antihypertensive
agents and furosemide for a target BP at the 50th percen-
tile for height with close follow up.
Long-term management
Over a 6-month period she remained on three or four anti-
hypertensive medications which were adjusted to target a
BP below 112/66 mmHg (50th percentile for height). In
addition, she was started on epoetin alpha 2000 units2
weekly, calcitriol 0.25 µg daily, sodium bicarbonate 1300
mg twice daily and calcium acetate 667 mg tab with food
for chronic kidney disease (CKD) management. Kidney
function improved (creatinine declined to 265.2 µmol/L
(3 mg/dL); eGFR 24 mL/min/1.73 m2), anemia was treated
to a target of <6.8 mmol/L (11 g/dL) (she required no
transfusions), and serum phosphorous was consistently
less than 1.94 mmol/L (6 mg/dL). However, she had inter-
mittent periods of altered mental status and developed
chronic headaches. Each episode was in the context of a
presumed vasovagal/pre-syncopal episode.
One episode occurred during a hot shower. Upon
getting out of the shower, she developed vertigo and
ataxia and fell to the floor. She was evaluated in an emer-
gency room (ER). She had a normal examination. BP in the
ER was 105/60 mmHg. She was given fluids and had good
urine output. Her symptoms were attributed to aggressive
BP control. Clonidine was discontinued and furosemide
was decreased by half the dose to 20 mg twice a day.
A second episode was associated with severe headache
and occurred at school. When getting up from her desk
Figure 1. (A) MRI without contrast enhancement FLAIR signal showing
hyperintensity in the right parietal lobe (white arrow), head of caudate
nucleus (asterisk) and adjacent white matter. (B) Sequential image of
series showing hyperintensity in the temporal lobe (short arrow), putamen
(double asterisks) and right parietal lobe (long arrow). MRI, magnetic
resonance imaging; FLAIR, fluid attenuated inversion recovery.
Figure 2. MRAwithout contrast enhancement using time-of-flight technique
shows diminished flow in right MCA M1 (white arrow) and bilateral ACA A1
segments (black arrows). MRA, magnetic resonance angiography; MCA,
middle cerebral artery; ACA, anterior cerebral artery.
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she became ‘dizzy’, began seeing ‘spots’, and was nau-
seated. The school nurse recorded her BP at 110/63
mmHg. Neurological examination in the ER was normal
with a BP of 117/72 mmHg. The headache was character-
ized as band like, associated with photo- and phonophobia.
She was diagnosed with a migraine headache. Atenolol
was changed to extended release metoprolol 25 mg and
amitriptyline 10 mg nightly was prescribed.
A few weeks later the patient noticed a subtle numb-
ness in her left hand and leg. She preferred receiving the
epoetin alpha injection in her left thigh because she
noticed that it hurt less. Two days prior to readmission,
her father stepped on her foot and it did not hurt! On the
day of readmission, she developed facial numbness ‘I felt
like I was at the dentist and somebody gave me novocain’.
Her left arm felt heavy and clumsy. She presented to her
primary medical doctor who referred her to the ER. On
physical examination, BP was 126/75 mmHg. She had new
left-sided arm weakness with numbness to light touch as
well as decreased sensation to pin and temperature on
the left side of the face. Although in the past we had been
reluctant to use iodinated contrast, in the setting of a new
focal deficit, a conventional angiogram of the central
nervous system (CNS) with iodinated contrast was per-
formed. It was consistent with moyamoya disease
(Figure 4).
Figure 3. Graphical representation of patient’s blood pressure, target ranges and medications prescribed during initial hospitalization.
Figure 4. (A) CNS angiogram shows an early time point of the study highlighting a tightly stenosed terminal right internal carotid artery (white arrow)
with collateral lenticulostriate vessels (black arrow). (B) Later time point of study with asterisk indicating ‘puff of smoke’ appearance because of the
collateral flow through the numerous lenticulostriate vessels.
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Upon the diagnosis of moyamoya, aggressive BP control
for a target below the 50th percentile was recognized as
potentially detrimental and contributory to her neurologi-
cal symptoms. She recovered left-sided strength within
24 h. The target BP was revised to maintain a goal between
the 50th and 95th percentile (she remained on lisinopril
10 mg twice daily, amlodipine 10 mg daily, metoprolol
ER 25 mg daily and furosemide 20 mg twice daily). Two
weeks after the angiogram identified moyamoya, she un-
derwent a right-sided encephaloduroarteriosynangiosis
(EDAS) with pial synangiosis revascularization. BP medi-
cations were held 24 h prior to surgery. She was discharged
on post-operative day 6. Since the surgery BP targets remain
above the 50th percentile and the calcium-channel blocker
and beta-blocker have been discontinued. BP is controlled
on lisinopril 10 mg twice daily and furosemide 20 mg daily.
Case discussion
Hypertensive crises are caused by severe hypertension
and can be divided into two categories: emergent or
urgent. Hypertensive emergencies are occurring when
there is evidence of evolving injury to the cardiovascular
system (heart failure, pulmonary edema), kidneys (renal
failure) or CNS (seizures, altered mental status, transient
ischemia, stroke) due to endothelial damage from shear
stress. Hypertensive urgency is defined as the presence of
severe hypertension with no acute end-organ damage.
Pediatric hypertensive emergencies are rare. This is in
stark contrast to adult medicine where it is reported that
of the 27% of the adult population affected by hyperten-
sion, 1% of these patients will at some point develop a hy-
pertensive crisis [1]. Furthermore, 25% of all adult patient
visits to the ER are related to hypertension and in one-
third of these cases a hypertensive emergency is occurring
[2]. In pediatrics, the causes of hypertension and hyper-
tensive crisis vary by age although after the age of
6 years, primary hypertension is the most common cause.
However, severe pediatric hypertension, which is com-
monly defined as a level 20 mmHg above the 95th percen-
tile for height is most often secondary [3]. Renal disease is
the most common cause of secondary hypertension and
hypertensive crises [4]. In our patient, it was presumed
that the presentation of hypertensive encephalopathy
was due to renal failure from reflux nephropathy.
Reflux nephropathy is a recognized cause of both renal
failure and hypertensive renal crisis in adolescent patients
[3]. Although our patient’s renal failure was precipitous,
hypertension is a major risk for progression of CKD and we
believed that the hypertensive crisis further accelerated
the progression. A kidney biopsy was not performed
because it was felt that the renal ultrasound was consist-
ent with chronic VUR and therefore was unlikely to change
management; while at the same time there would be a
high likelihood of bleeding complications due to the un-
controlled hypertension and renal failure during biopsy.
Her neurological status returned to baseline without any
focal deficits. She was discharged home with a diagnosis
of PRES and CKD. She was placed on an intensive BP
regime with twice daily monitoring and target BPs at or
below the 50th percentile based upon favorable outcomes
from the Effect of Strict Blood Pressure control and ACE
inhibition on the Progression of CRF in Pediatric patients
(ESCAPE) trial group [5]. We originally deferred cerebral
angiogram because of the renal failure.
In hindsight, it was appreciated that the episodes of
altered mental status were ischemic in nature and not va-
sovagal. The aggressive BP control in an attempt to slow
progression of CKD and avoid dialysis actually induced
transient CNS ischemia—unmasking moyamoya. Moya-
moya is an occlusive disease of the cerebral vasculature
involving the internal carotid arteries with the develop-
ment of collateral circulation from the leptomeninges and
branches of the external carotid [6]. The collateral circula-
tion has the appearance of a ‘puff of smoke’—the trans-
lation for the Japanese word ‘moyamoya’. Although
pediatric moyamoya has been associated with severe hy-
pertension [7–10], we believe that this case is the first to
present as a hypertensive emergency with renal failure
and highlights this disease for consideration in the differ-
ential diagnosis of hypertensive renal failure (Table 1).
There are two possible mechanisms of hypertension
related to moyamoya disease: (i) systemic compensation
due to cerebral hypoperfusion or (ii) fibromuscular dyspla-
sia of the renal arteries with resultant renovascular hyper-
tension. The occlusive vasculopathy of moyamoya can be
systemic and affect the vasculature of a number of organ
systems. Renal artery stenosis (RAS) occurs in 7% of the
Japanese population with moyamoya [11]. However, chil-
dren are disproportionately affected (a breakdown shows
that 45% were children) [8, 11, 12]. In a more hetero-
geneous population, 20% of children with moyamoya also
had RAS according to a study from Great Ormond Street
Hospital [8].
A renal angiogram was performed at the time of the
CNS study (Figure 5). No evidence of RAS was found,
although there was ‘pruning of the distal arteries consist-
ent with chronic kidney disease’. Therefore, it seems that
in our patient the hypertension was due to compensation
from cerebral hypoperfusion. This is again unique as all
previous cases of renal failure associated with moyamoya
have documented RAS. We appreciate that the occlusive
vasculopathy of moyamoya can involve small arteries
and therefore cannot entirely ascribe the findings of the
angiogram to CKD with absolute certainty. Therefore, we
support that in the setting of hypertension and moya-
moya disease, evaluation of the renal vasculature with
imaging and plasma renin levels should be performed and
a strong suspicion for RAS should be maintained [13].
Our patient underwent an indirect revascularization of
the CNS by an EDAS procedure. This technique involves
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placement of vascularized tissue supplied by the external
carotid artery (which is not typically affected by moya-
moya) in direct contact with the brain. This then leads to
in-growth of new blood vessels ‘vascularizing’ the under-
lying ischemic area [6]. Surgical revascularization has
gained acceptance as a primary treatment for moyamoya.
The greatest risk for stroke after revascularization is within
the first 30 days (reportedly 4% per hemisphere).
However, thereafter the probability of being stroke-free at
5 years is 96% [6, 14, 15]. Since surgery we have been able
to wean antihypertensive agents, a phenomenon which
has been previously described [16]. This further supports
that hypertension was not renovascularly but cerebrovas-
cularly driven.
In conclusion, this case highlights that moyamoya must
be considered in the differential diagnosis of patients pre-
senting with hypertensive emergency and renal failure.
Although CKD is a major risk factor of hypertensive emer-
gencies with reports indicating that 79% of adult patients
have CKD stage 2 or greater [17], there are a number of
causes that must be considered (Table 1). We attributed
the hypertensive emergency to CKD causing acute kidney
injury and PRES. We were pleased as neurological status
and kidney function improved potentially inducing diag-
nostic inertia. However, the long-term management of
CKD with aggressive BP control induced transient ischemia
because of moyamoya. Recognition of moyamoya led to
surgical revascularization and has changed our medical
management to accept higher blood pressures up to the
90th percentile.
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Figure 5. Renal angiogram. Single renal arteries (white arrows) with no
ostial stenosis. Both renal arteries show distal pruning consistent with CKD.
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